The information in the table below represents an industry comparison of businesses which are of the same relative size. This is based on BBB's database of businesses located in the Counties of Los Angeles, Santa Clara, Santa Cruz, Monterey and San Benito. Businesses may engage in more than one type of business. The percent of time the business engages in a type of business is not accounted for. There is no known industry standard for the number of complaints a business can expect. The volume of business and number of transactions may have a bearing on the number of complaints received by BBB.
*Lunada Biomedical is in this range.
Types of Complaints Handled by BBB
BBB handles the following types of complaints between businesses and their customers so long as they are not, or have not been, litigated:
- Advertising or Sales
- Billing or Collection
- Problems with Products or Services
- Guarantee or Warranty
We do not handle workplace disputes, discrimination claims or claims about the quality of health or legal services.
BBB Complaint Process
Your complaint will be forwarded to the company within two business days. The company will be asked to respond within 14 days, and if a response is not received, a second request will be made. You will be notified of the company's response when we receive it (or notified that we received no response). Complaints are usually closed within 30 business days.
What is BBB Advertising Review?
BBB promotes truth in advertising by contacting advertisers whose claims conflict with the BBB Code of Advertising. These claims come to our attention from our internal review of advertising, consumer complaints and competitor challenges. BBB asks advertisers to prove their claims, change ads to make offers more clear to consumers, and remove misleading or deceptive statements.
About BBB Business Review Content and Services
Some Better Business Bureaus offer additional content and services in BBB Business Reviews. The additional content and services are typically regional in nature or, in some cases, a new product or service that is being tested prior to a more general release. Not all enhanced content and services are available at all Better Business Bureaus.
May 20, 2016 - Lunada Biomedical, Inc. and its three principals have settled Federal Trade Commission charges that they deceptively marketed Amberen, a dietary supplement, to women over 40 who are perimenopausal or menopausal, making a range of unsupported claims about its ability to help users lose weight and belly fat, and relieve menopause-related symptoms such as hot flashes and night sweats.
The proposed stipulated order bars the defendants from making unsubstantiated efficacy or health benefit claims for any dietary supplement, food, or drug, as well as other illegal conduct
The FTC filed its original complaint in May 2015 and an amended complaint in December 2015. The amended complaint alleges that the defendants made unsubstantiated claims that their dietary supplement, Amberen, causes substantial and sustained weight loss, loss of belly fat, and an increase in metabolism in women over 40 who are perimenopausal or menopausal, and false claims that Amberen is clinically proven to cause substantial and sustained weight loss in those women.
The Commission also alleged that the defendants made unsubstantiated claims that Amberen alleviates nearly every common symptom of menopause, including hot flashes, night sweats, sleep problems, fatigue, and irritability, and false claims that the product is clinically proven to provide these benefits.
The amended complaint further alleges that the defendants failed to disclose their relationship with certain consumer endorsers and falsely claimed consumer satisfaction and success rates of nearly 93 percent and that consumers could try Amberen "risk-free" for 30 days.
The proposed order settling the FTC's charges prohibits the defendants from: 1) claiming that any dietary supplement, food, or drug causes weight loss, sustained weight loss, or loss of belly fat; boosts metabolism; relieves hot flashes, night sweats, and other specific symptoms of menopause; or cures, mitigates, or treats any disease, unless they have human clinical testing that meets certain requirements and is sufficient to substantiate that the claims are true, 2) making any misleading or unsubstantiated claim about the health benefits or efficacy of any dietary supplement, food, or drug; 3) misrepresenting the results of any test of the product; 4) misrepresenting any material fact about the product or any material terms and conditions of any offer for it; and 5) failing to disclose any material connections (such as financial relationships) they have with endorsers. They also are subject to a $40 million judgment, all but $250,000 of which will be suspended based on their inability to pay.